This was a significant increase in ambition setting the company on a path towards net-zero GHG emissions across its entire value chain by 2050. Then in 2022, Boston Scientific was once again one of the first companies in the Healthcare Equipment and Supplies sector to have net-zero, science-based Scope 1, 2 and 3 targets approved by SBTi, the predominate third-party net-zero target assessment organisation. In 2021, Boston Scientific expanded its climate action goals by joining the United Nations Race to Zero and Science Based Targets initiative (SBTi) Business Ambition for 1.5☌ campaign. Since then, the three Irish sites have been powered with 100% renewable electricity through supplier agreements. In 2019, the company’s manufacturing sites located in Clonmel, Cork and Galway achieved the ISO 50001:2018 energy management certification – supporting objective, continual energy performance monitoring. In 2017, Boston Scientific was one of the first medical device manufacturers to pledge carbon neutrality for scope 1 and 2 greenhouse gas (GHG) emissions in all manufacturing and key distribution sites by 2030. Then came the GEMS framework in 2013 which was quickly followed by a range of milestone years. The company received ISO 14001 certification for Galway in 2001 – ensuring an effective environmental system that could be measured and improved. To achieve its ambitious goals, Boston Scientific has been making a number of investments not only in Ireland but also across the full breadth of its global operations. The common goal was clear: the companies were all paying a high energy rate – and this began the first driver to cut fossil fuel use and to transition towards less expensive and more efficient options where available.Įileen Sharpe, Executive Vice President, IDA Ireland Turning theory into action Because of this, energy conservation fast became a very important element of running operations in Ireland and it ultimately started to bring the manufacturing industry together – and began what would become a core element of operating in Ireland for many organisations: collaboration.Ī leading example of what this collaboration can achieve was demonstrated by a government-sponsored technology centre, known as I2E2, which was formed to enable the Irish manufacturing industry to improve competitiveness via breakthroughs in energy efficiency and cost reduction. With the company shipping well in excess of four million products from Ireland to the rest of the world – including defibrillators, pacemakers, heart stents and valves, vascular balloons, deep brain stimulators, catheters, coils and oesophageal stents – there was a heightened pressure for operational efficiency and high performance.īut twenty years ago, high-electricity costs in Ireland were a major obstacle for U.S.-headquartered companies – with a kilowatt-hour costing double in Ireland compared to mainland U.S. Boston Scientific has had a presence in Ireland for nearly 30 years – establishing its first site in Galway in 1994.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |